Entrada Therapeutics Inc TRDA:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
12.70quote price arrow up+0.09 (+0.71%)
Volume
31,421
52 week range
5.12 - 36.85
Loading...
  • Open13.72
  • Day High13.72
  • Day Low11.78
  • Prev Close12.61
  • 52 Week High36.85
  • 52 Week High Date11/18/21
  • 52 Week Low5.12
  • 52 Week Low Date05/09/22

Key Stats

  • Market Cap398.40M
  • Shares Out31.37M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-25.82

KEY STATS

  • Open13.72
  • Day High13.72
  • Day Low11.78
  • Prev Close12.61
  • 52 Week High36.85
  • 52 Week High Date11/18/21
  • 52 Week Low5.12
  • 52 Week Low Date05/09/22
  • Market Cap398.40M
  • Shares Out31.37M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-25.82

RATIOS/PROFITABILITY

  • EPS (TTM)-8.16
  • P/E (TTM)-1.56
  • Fwd P/E (NTM)-3.96
  • EBITDA (TTM)-50.01M
  • ROE (TTM)-
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Entrada Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Entrada Therapeutics, Inc. (Entrada) is a biopharmaceutical company aiming to transform the lives of patients by establishing a set of medicines, Endosomal Escape Vehicles (EEV) therapeutics, to engage intracellular targets that are considered inaccessible and undruggable. The Company's EEV therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues with an improved therapeutic index. Through...
Kush Parmar M.D., Ph.D.
Non-Executive Independent Chairman of the Board
Dipal Doshi
President, Chief Executive Officer, Director
Nathan Dowden
Chief Operating Officer
Kory Wentworth CPA
Chief Financial Officer
Jared Cohen J.D., Ph.D.
General Counsel
Address
6 Tide Street
Boston, MA
02210
United States

Top Peers

SYMBOLLASTCHG%CHG
KALV
Kalvista Pharmaceuticals Inc
13.76+0.05+0.36%
BMEA
Biomea Fusion Inc
11.50-0.42-3.52%
CBAY
Cymabay Therapeutics Inc
3.74-0.42-10.10%
ABSI
Absci Corp
4.79+0.59+14.05%
ICVX
Icosavax Inc
8.41+0.15+1.82%